Sanofi reports positive data from Phase III EoE treatment trial

Sanofi reports positive data from Phase III EoE treatment trial

Source: 
Clinical Trials Arena
snippet: 

Sanofi has announced the publication of positive results from a Phase III clinical trial of Dupixent (dupilumab) in one to 11-year-old children with eosinophilic esophagitis (EoE).